Quick Takeaways
- Kimberly Gentile has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $988,601.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Kimberly Gentile
- Location
- New Haven, CT
- Summary
- The estimated net worth of Kimberly Gentile is at least $988,601 dollars as of 03 Mar 2026. Kimberly Gentile is the SVP, Clinical Operations of Biohaven Ltd. and owns shares of Biohaven Ltd. (BHVN) stock worth about $988.6K.
- Signature
- /s/ George Clark, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kimberly Gentile and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Biohaven Ltd. ($988,601).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Kimberly Gentile
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BHVN | Biohaven Ltd. | SVP, Clinical Operations | $988,601 | 27 Feb 2026 | ||
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | SVP, Clinical Operations | 03 Oct 2022 |
Insider Transactions Reported by Kimberly Gentile:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.